Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6307) 6307
Newsletter (124) 124
Dissertation (37) 37
Magazine Article (25) 25
Book Chapter (21) 21
Newspaper Article (20) 20
Publication (17) 17
Book / eBook (4) 4
Web Resource (3) 3
Book Review (2) 2
Conference Proceeding (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4442) 4442
life sciences & biomedicine (4301) 4301
humans (3679) 3679
male (3293) 3293
citalopram (2996) 2996
female (2615) 2615
citalopram - therapeutic use (2138) 2138
psychiatry (2131) 2131
adult (1914) 1914
biological and medical sciences (1824) 1824
medical sciences (1675) 1675
pharmacology & pharmacy (1674) 1674
neurosciences & neurology (1633) 1633
middle aged (1568) 1568
animals (1504) 1504
neurosciences (1415) 1415
citalopram - pharmacology (1409) 1409
antidepressants (1357) 1357
pharmacology. drug treatments (1333) 1333
serotonin uptake inhibitors - therapeutic use (1173) 1173
psychology. psychoanalysis. psychiatry (1161) 1161
depression (1047) 1047
neuropharmacology (1043) 1043
treatment outcome (1041) 1041
psychopharmacology (1006) 1006
aged (962) 962
citalopram - adverse effects (958) 958
rats (916) 916
serotonin uptake inhibitors - pharmacology (913) 913
serotonin (883) 883
depressive disorder, major - drug therapy (869) 869
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (832) 832
citalopram - administration & dosage (777) 777
clinical neurology (680) 680
double-blind method (658) 658
escitalopram (654) 654
antidepressive agents, second-generation - therapeutic use (615) 615
antidepressive agents - therapeutic use (614) 614
serotonin uptake inhibitors (607) 607
serotonin uptake inhibitors - adverse effects (599) 599
adolescent (596) 596
depression, mental (573) 573
psychopathology. psychiatry (570) 570
dose-response relationship, drug (535) 535
depressive disorder - drug therapy (513) 513
drug therapy (500) 500
adult and adolescent clinical studies (490) 490
analysis (475) 475
serotonin - metabolism (465) 465
young adult (462) 462
mental depression (450) 450
depression - drug therapy (443) 443
serotonin uptake inhibitors - administration & dosage (443) 443
psychiatric status rating scales (434) 434
mood disorders (423) 423
psychology (401) 401
fluoxetine (400) 400
research (400) 400
social sciences (388) 388
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer (380) 380
antidepressive agents - pharmacology (379) 379
time factors (377) 377
rats, sprague-dawley (376) 376
mice (357) 357
mental disorders (342) 342
drug therapy, combination (340) 340
antidepressant (326) 326
ssri (319) 319
major depressive disorder (315) 315
paroxetine (306) 306
abridged index medicus (305) 305
antidepressive agents, second-generation - adverse effects (297) 297
citalopram - pharmacokinetics (288) 288
drug interactions (287) 287
rats, wistar (286) 286
sertraline (282) 282
brain - metabolism (274) 274
care and treatment (274) 274
fundamental and applied biological sciences. psychology (271) 271
clinical trials (270) 270
anxiety (269) 269
depressive disorder, major - psychology (269) 269
aged, 80 and over (266) 266
drugs (265) 265
brain - drug effects (258) 258
biochemistry & molecular biology (256) 256
severity of illness index (253) 253
neurology (252) 252
health aspects (245) 245
risk factors (241) 241
dosage and administration (234) 234
brain (226) 226
citalopram - blood (224) 224
physical sciences (224) 224
drug administration schedule (220) 220
chemistry (218) 218
toxicology (216) 216
antidepressive agents - adverse effects (215) 215
psychology, clinical (212) 212
general & internal medicine (204) 204
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6292) 6292
German (72) 72
French (54) 54
Russian (36) 36
Spanish (28) 28
Portuguese (26) 26
Chinese (19) 19
Czech (18) 18
Polish (16) 16
Italian (12) 12
Dutch (11) 11
Japanese (11) 11
Swedish (11) 11
Danish (10) 10
Hungarian (10) 10
Turkish (8) 8
Norwegian (5) 5
Persian (5) 5
Slovak (4) 4
Finnish (3) 3
Korean (3) 3
Hebrew (2) 2
Ukrainian (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Antidepressant Drugs Citalopram and Escitalopram but not Paroxetine Induce Arrythmogenic Sarcoplasmic Reticulum Calcium Release
by Blackwell, Daniel and Knollmann, Björn
Biophysical journal, ISSN 0006-3495, 02/2017, Volume 112, Issue 3, pp. 95a - 95a
Paroxetine | Citalopram
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?
by Sanchez, Connie and Reines, Elin H and Montgomery, Stuart A
International clinical psychopharmacology, ISSN 0268-1315, 07/2014, Volume 29, Issue 4, pp. 185 - 196
allosteric | selective serotonin reuptake inhibitor | serotonin | paroxetine | major depressive disorder | serotonin transporter | escitalopram (S-citalopram) | sertraline | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Depression | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Paroxetine - pharmacokinetics | Antidepressive Agents, Second-Generation - adverse effects | Antidepressive Agents, Second-Generation - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacokinetics | Citalopram - pharmacology | Depressive Disorder, Major - metabolism | Humans | Citalopram - adverse effects | Paroxetine - therapeutic use | Sertraline - adverse effects | Antidepressive Agents, Second-Generation - therapeutic use | Paroxetine - adverse effects | Depression - drug therapy | Serotonin Plasma Membrane Transport Proteins - chemistry | Depression - metabolism | Nerve Tissue Proteins - chemistry | Drug Interactions | Sertraline - pharmacokinetics | Sertraline - therapeutic use | Depressive Disorder, Major - drug therapy | Nerve Tissue Proteins - antagonists & inhibitors | Sertraline - pharmacology | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Antidepressive Agents, Second-Generation - pharmacology | Evidence-Based Medicine | Nerve Tissue Proteins - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Animals | Models, Biological | Allosteric Site | Citalopram - pharmacokinetics | Citalopram - therapeutic use | Paroxetine - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text X-ray structures and mechanism of the human serotonin transporter
by Coleman, Jonathan A and Green, Evan M and Gouaux, Eric and Argonne National Lab. (ANL), Argonne, IL (United States)
Nature (London), ISSN 0028-0836, 04/2016, Volume 532, Issue 7599, pp. 334 - 339
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Citalopram - pharmacology | Humans | Protein Conformation - drug effects | Crystallography, X-Ray | Dopamine Plasma Membrane Transport Proteins - chemistry | Structure-Activity Relationship | Antidepressive Agents - metabolism | Citalopram - metabolism | Serotonin Plasma Membrane Transport Proteins - chemistry | Extracellular Space - metabolism | Antidepressive Agents - chemistry | Protein Binding - drug effects | Drug Design | Antidepressive Agents - pharmacology | Protein Stability | Allosteric Regulation - drug effects | Ions - chemistry | Serotonin Plasma Membrane Transport Proteins - immunology | Allosteric Site - drug effects | Models, Molecular | Ions - metabolism | Paroxetine - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Citalopram - chemistry | Intracellular Space - metabolism | Serotonin - metabolism | Ligands | Immunoglobulin Fab Fragments - immunology | Paroxetine - pharmacology | Paroxetine - chemistry | Drug metabolism | Paroxetine | Physiological research | Research | Serotonin | Binding sites (Biochemistry) | X rays | Mutation | Antidepressants | Binding sites | Index Medicus | X-ray crystallography | Transporters in the nervous system | BASIC BIOLOGICAL SCIENCES | Membrane proteins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Micellar liquid chromatographic method for the simultaneous determination of citalopram hydrobromide with its two demethylated metabolites. Utility as a diagnostic tool in forensic toxicology
by El Sherbiny, D and Wahba, M.E.K
Journal of pharmaceutical and biomedical analysis, ISSN 0731-7085, 02/2019, Volume 164, pp. 173 - 180
Desmethyl citalopram | Didesmethyl citalopram | Forensic toxicology | Micellar liquid chromatography | Citalopram | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Chemistry, Analytical | Life Sciences & Biomedicine | Science & Technology | Limit of Detection | Reproducibility of Results | Chromatography, High Pressure Liquid - methods | Myocardium - chemistry | Tablets | Forensic Toxicology - instrumentation | Rats | Chromatography, High Pressure Liquid - instrumentation | Liver - chemistry | Animals | Autopsy | Chemical Fractionation | Spectrophotometry, Ultraviolet - methods | Micelles | Citalopram - analogs & derivatives | Models, Animal | Forensic Toxicology - methods | Citalopram - analysis | Spectrophotometry, Ultraviolet - instrumentation | Phosphates | Phosphoric acid | Metabolites | Pharmacy | Drugstores | Liquid chromatography | Methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Comparative performances of a bare graphite-polyurethane composite electrode unmodified and modified with graphene and carbon nanotubes in the electrochemical determination of escitalopram
by Baccarin, Marina and Cervini, Priscila and Cavalheiro, Eder Tadeu Gomes
Talanta (Oxford), ISSN 0039-9140, 02/2018, Volume 178, pp. 1024 - 1032
Carbon nanotubes | Antidepressant determination | Graphite-polyurethane composite electrode | Escitalopram | Graphene | Physical Sciences | Chemistry | Chemistry, Analytical | Science & Technology | Electrodes | Citalopram - chemistry | Limit of Detection | Nanotubes, Carbon - chemistry | Polyurethanes - chemistry | Citalopram - cerebrospinal fluid | Citalopram - urine | Graphite - chemistry | Citalopram - analysis | Electrochemistry - instrumentation | Electrochemical reactions | Graphite | Nanotubes | Sensors | Comparative analysis | Raman spectroscopy | Polyurethanes | Electric properties | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression
by Brunoni, Andre R and Moffa, Adriano H and Sampaio-Junior, Bernardo and Borrione, Lucas and Moreno, Marina L and Fernandes, Raquel A and Veronezi, Beatriz P and Nogueira, Barbara S and Aparicio, Luana V.M and Razza, Lais B and Chamorro, Renan and Tort, Luara C and Fraguas, Renerio and Lotufo, Paulo A and Gattaz, Wagner F and Fregni, Felipe and Benseñor, Isabela M and ELECT-TDCS Investigators
The New England journal of medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 26, pp. 2523 - 2533
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antidepressive Agents, Second-Generation - adverse effects | Heart Rate | Double-Blind Method | Humans | Middle Aged | Citalopram - adverse effects | Depressive Disorder, Major - therapy | Antidepressive Agents, Second-Generation - therapeutic use | Bipolar Disorder - etiology | Psychiatric Status Rating Scales | Transcranial Direct Current Stimulation - adverse effects | Intention to Treat Analysis | Biomarkers | Adult | Citalopram - therapeutic use | Transcranial Direct Current Stimulation - methods | Aged | Depressive Disorder, Major - drug therapy | Treatment outcome | Care and treatment | Usage | Electroconvulsive therapy | Depression, Mental | Patient outcomes | Serotonin uptake inhibitors | Dosage and administration | Comparative analysis | Transcranial magnetic stimulation | Serotonin | Clinical trials | Mental depression | Citalopram | Electrical currents | Motivation | Affective disorders | Antidepressants | Skin | Tinnitus | Drug therapy | Psychiatry | Sleep and wakefulness | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Escitalopram versus citalopram: the surprising role of the R-enantiomer
by Sánchez, Connie and Bøgesø, Klaus P and Ebert, Bjarke and Reines, Elin Heldbo and Braestrup, Claus
Psychopharmacology, ISSN 0033-3158, 7/2004, Volume 174, Issue 2, pp. 163 - 176
Medicine | Antidepressant | SSRI | Serotonin transporter | Escitalopram | Panic disorder | Depression | R -citalopram | Stereochemistry | Enantiomers | Citalopram | R-citalopram | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Fundamental and applied biological sciences. Psychology | Psychology. Psychoanalysis. Psychiatry | Psychology. Psychophysiology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Neuropharmacology | Stereoisomerism | Humans | Panic Disorder - drug therapy | Serotonin Uptake Inhibitors - therapeutic use | Rats | Serotonin Uptake Inhibitors - chemistry | Structure-Activity Relationship | Randomized Controlled Trials as Topic | Brain - drug effects | Brain - metabolism | Citalopram - chemistry | Animals | Drug Interactions | Behavior, Animal - drug effects | Citalopram - therapeutic use | Mice | Depressive Disorder, Major - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Integrin [ALPHA]V[BETA]3 Function Influences Citalopram Immobility Behavior in the Tail Suspension Test
by Pan, Hope and Dohn, Michael R and Kingston, Rody and Carneiro, Ana M.D
Frontiers in neuroscience, ISSN 1662-453X, 02/2019
Integrins | Citalopram
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study
by Devos, David and Dujardin, Kathy and Poirot, Isabelle and Moreau, Caroline and Cottencin, Olivier and Thomas, Pierre and Destée, Alain and Bordet, Regis and Defebvre, Luc
Movement disorders, ISSN 0885-3185, 04/2008, Volume 23, Issue 6, pp. 850 - 857
norepinephrine | antidepressant treatment | serotonin | Parkinson's disease | depression | Parkinson disease | Depression | Norepinephrine | Antidepressant treatment | Serotonin | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Prevalence | Double-Blind Method | Humans | Middle Aged | Citalopram - adverse effects | Male | Parkinson Disease - psychology | Antidepressive Agents - therapeutic use | Depression - etiology | Depression - drug therapy | Desipramine - adverse effects | Psychiatric Status Rating Scales | Desipramine - therapeutic use | Placebos | Citalopram - therapeutic use | Female | Aged | Antidepressive Agents - adverse effects | Index Medicus | Desipramine | Neurons and Cognition | Antidepressive Agents | Citalopram | Parkinson Disease | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors
by Nisa, Mehr-un and Munawar, Munawar A and Iqbal, Amber and Ahmed, Asrar and Ashraf, Muhammad and Gardener, Qurra-tul-Ann A and Khan, Misbahul A
European journal of medicinal chemistry, ISSN 0223-5234, 09/2017, Volume 138, pp. 396 - 406
Enzyme inhibition | Acetylcholinesterase | Butyrylcholinesterase | Escitalopram | Alzheimer's disease | Citalopram - chemical synthesis | Citalopram - pharmacology | Cholinesterase Inhibitors - chemistry | Electrophorus | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Dose-Response Relationship, Drug | Citalopram - chemistry | Animals | Cholinesterase Inhibitors - pharmacology | Butyrylcholinesterase - metabolism | Citalopram - analogs & derivatives | Horses | Molecular Structure | Acetylcholinesterase - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: A randomized cross-over study
by Windischberger, Christian and Lanzenberger, Rupert and Holik, Alexander and Spindelegger, Christoph and Stein, Patrycja and Moser, Ulrike and Gerstl, Florian and Fink, Martin and Moser, Ewald and Kasper, Siegfried
NeuroImage (Orlando, Fla.), ISSN 1053-8119, 01/2010, Volume 49, Issue 2, pp. 1161 - 1170
SSRI | Serotonin | Escitalopram | Pharmacological fMRI | Citalopram | Neuroimaging | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Citalopram - pharmacology | Visual Perception - drug effects | Citalopram - blood | Humans | Male | Brain - physiology | Brain - blood supply | Adult | Female | Serotonin Uptake Inhibitors - blood | Visual Perception - physiology | Double-Blind Method | Cerebrovascular Circulation - drug effects | Facial Expression | European Continental Ancestry Group | Executive Function - physiology | Emotions | Oxygen - blood | Brain - drug effects | Cross-Over Studies | Neuropsychological Tests | Magnetic Resonance Imaging | Citalopram - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Brain Mapping | Serotonin Uptake Inhibitors - pharmacology | Executive Function - drug effects | Clinical trials | Medical colleges | Anxiety | Studies | Brain | Anxieties | Antidepressants | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights